Gene expression profiles revealed that the activation of the NF-κB and/or JAK/STAT3 pathways are characteristics of EBV+ DLBCL, even when compared with ABC type EBV- DLBCL [4, 10]. This evidence concerns the gene STAT3 and diffuse large B-cell lymphoma.